Plasma Cytokine Levels As Predictors of Global and Domain-Specific Human Immunodeficiency Virus-Associated Neurocognitive Impairment in Treatment-Naive Individuals
Central nervous system dysfunction, associated with human immunodeficiency virus (HIV) infection, remains a significant clinical concern, affecting at least 50% of infected people. Imbalances in cytokine expression levels have been linked to HIV-associated neurocognitive disorders. The aim of this s...
Saved in:
Published in: | Journal of interferon & cytokine research Vol. 41; no. 4; p. 153 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
01-04-2021
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Central nervous system dysfunction, associated with human immunodeficiency virus (HIV) infection, remains a significant clinical concern, affecting at least 50% of infected people. Imbalances in cytokine expression levels have been linked to HIV-associated neurocognitive disorders. The aim of this study was to evaluate plasma cytokine levels as predictor neurocognitive impairment in HIV infection using a multiplex profiling kit. Stepwise regression model was used to identify cytokine biomarkers of overall and domain-specific cognitive performance. Higher interleukin (IL)-2 (
= 0.04;
= 0.001) and eotaxin (
= 0.01;
= 0.017) were predictors of global neurocognitive, whereas higher IL-5 (
= 0.005;
= 0.007) was negative predictor of global cognitive deficit. IL-2 was a negative predictor of most cognitive domain functions, including recall (
= 0.24;
= 0.005), recognition (
= 0.04;
= 0.026), mental control (
= 0.38;
= 0.005), symbol search (
= -0.55;
= 0.001), and digital symbol (
= -0.79;
= 0.019). IL-6 was associated with 3 impaired domains, mental processing (
= -0.468;
= 0.027), recognition (
= -0.044;
= 0.012), and learning (
= 0.02668;
= 0.020) These results show that plasma cytokines/chemokines may serve as markers of neurocognitive impairment in HIV infection. |
---|---|
ISSN: | 1557-7465 |
DOI: | 10.1089/jir.2020.0251 |